InvestorsHub Logo
Followers 1
Posts 121
Boards Moderated 0
Alias Born 02/28/2013

Re: None

Monday, 03/04/2013 3:56:35 PM

Monday, March 04, 2013 3:56:35 PM

Post# of 125
Patient compliance is a key to the success of this company. IMO...If (a big if) the bio-pump fulfills the potential and is approved it holds the promise to revolutionize protein therapy as we know it.

I know from personal experience that compliance is a major influence as to the effectiveness of any treatment. The bio-pump will, without question, improve patient compliance across all bio-pump platforms/indications.

I own a lump of MDGN stock. My investment in MDGN is based upon the platform, the management/board and my own personal belief (and my own DD) that the bio-pump could greatly improve the quality of life of MILLIONS cursed with protein issues.

Finally, if I financially gain from my speculative investment here then I know that Medgenics is on the way to improving life's...... and that is the type of profit that helps me sleep well at night!

Best of luck to everyone here supporting MDGN.

BMA
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.